Study Backs Benefits of Metformin in Prostate Cancer
Increased cumulative duration of metformin after a prostate cancer diagnosis correlates with decreased mortality in elderly men with diabetes.
Increased cumulative duration of metformin after a prostate cancer diagnosis correlates with decreased mortality in elderly men with diabetes.
There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn insulin.
Drugs designed to treat diabetes may also increase patients’ risk for pancreatic cancer.
For more than 50 years, an association between diabetes and an increased risk for cancer has been recognized and supported in numerous studies.
Physician empathy correlates with clinical outcome for patients with diabetes mellitus.
Patients with lower SBP fare worse than those with SBP between 130 and 160 when proteinuria is present.
Repeated measures of health behaviors, BMI account for about half of social differential.
Children and young adults who receive cancer radiotherapy face an increased risk of subsequently developing diabetes.
Meta-analysis of genetic variants on the Metabochip ID’d loci, two of which are sex-linked.
Neuronal responsiveness of the hypothalamus to glucose normalized in patients with type 2 diabetes.